Back To TOP

Genentech Rheumatology Co-pay Card Program

Genentech offers the Genentech Rheumatology Co-pay Card Program to help qualified patients with the out-of-pocket costs of their Rituxan® (rituximab) for rheumatoid arthritis (RA) prescription. For eligible patients, the card provides up to $10,000 in co-pay assistance per 12-month period, and patients must pay $5 per co-pay.

 

Some health plans might not accept a co-pay card. Patients should contact their insurance providers to find out if their plan allows the use of co-pay cards.

 

To verify your patients' eligibility or to enroll them in the co-pay card program, call Call (855) RA-COPAY (855-722-6729) or click Get Started.

activation image

 


 

 

Our simple eligibilty requirements
 
Eligible patients: Ineligible patients:
 
 
  • Use Rituxan for an approved indication
  • Have commercial insurance
  • Are over the age of 18
  • Receive free medicine from the Genentech® Access to Care Foundation or other sources
  • Have a federal or state government-funded health plan (eg, Medicare, Medicare Advantage, Medicaid, TRICARE)
  • Reside in any state where the program is prohibited by law

 

Learn More About
Rituxan for RA
  • LEARN about treatment with Rituxan
  • FIND the right patient assistance program with our Compass for Patient Access tool
  • LEARN HOW the Genentech Rheumatology Co-pay Card Program can help with the out-of-pocket costs for Rituxan for RA. It provides up to $10,000 per 12-month period.
  • Download: new forms for enrollment in GATCF
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.